Splenic tissue lipid membrane

Splenic tissue lipid membranes are the complex phospholipid bilayers that define the structural and functional boundaries of cells within the spleen, including macrophages, lymphocytes, and endothelial cells (Mebius & Kraal, 2005). These membranes are composed of various lipids such as phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin, which provide a matrix for membrane-bound proteins and facilitate the spleen's role in filtering aged erythrocytes and pathogens from the blood (Cesta, 2006). While not a discrete molecular therapeutic target like a specific receptor or enzyme, these membranes are central to the pathology of lysosomal storage diseases, such as Gaucher and Niemann-Pick diseases, where metabolic defects lead to the accumulation of lipids within the splenic architecture (Grabowski, 2005). In pharmacology, the splenic lipid environment is a primary site for the sequestration and clearance of liposomal drug delivery systems and nanoparticles by the mononuclear phagocyte system (Moghimi et al., 2001). Understanding the composition and fluidity of these membranes is essential for optimizing the biodistribution of encapsulated therapies and managing diseases that cause splenomegaly or membrane dysfunction.

Other names

Spleen cell membraneSplenic lipid bilayerSplenic plasma membrane

Sequestration and uptake by the mononuclear phagocyte system (MPS) within the splenic lipid environment, or substrate reduction therapy to prevent lipid accumulation.